Department of Mechanical Engineering, Stanford University, USA.
Pulm Circ. 2012 Oct;2(4):470-6. doi: 10.4103/2045-8932.105035.
Previous clinical studies in pulmonary arterial hypertension (PAH) have concentrated predominantly on distal pulmonary vascular resistance, its contribution to the disease process, and response to therapy. However, it is well known that biomechanical factors such as shear stress have an impact on endothelial health and dysfunction in other parts of the vasculature. This study tested the hypothesis that wall shear stress is reduced in the proximal pulmonary arteries of PAH patients with the belief that reduced shear stress may contribute to pulmonary endothelial cell dysfunction and as a result, PAH progression. A combined MRI and computational fluid dynamics (CFD) approach was used to construct subject-specific pulmonary artery models and quantify flow features and wall shear stress (WSS) in five PAH patients with moderate-to-severe disease and five age- and sex-matched controls. Three-dimensional model reconstruction showed PAH patients have significantly larger main, right, and left pulmonary artery diameters (3.5 ± 0.4 vs. 2.7 ± 0.1 cm, P = 0.01; 2.5 ± 0.4 vs. 1.9 ± 0.2 cm, P = 0.04; and 2.6 ± 0.4 vs. 2.0 ± 0.2 cm, P = 0.01, respectively), and lower cardiac output (3.7 ± 1.2 vs. 5.8 ± 0.6 L/min, P = 0.02.). CFD showed significantly lower time-averaged central pulmonary artery WSS in PAH patients compared to controls (4.3 ± 2.8 vs. 20.5 ± 4.0 dynes/cm(2), P = 0.0004). Distal WSS was not significantly different. A novel method of measuring WSS was utilized to demonstrate for the first time that WSS is altered in some patients with PAH. Using computational modeling in patient-specific models, WSS was found to be significantly lower in the proximal pulmonary arteries of PAH patients compared to controls. Reduced WSS in proximal pulmonary arteries may play a role in the pathogenesis and progression of PAH. This data may serve as a basis for future in vitro studies of, for example, effects of WSS on gene expression.
先前在肺动脉高压(PAH)中的临床研究主要集中在远端肺血管阻力上,以及它对疾病进程的贡献和对治疗的反应。然而,众所周知,生物力学因素如切应力会对血管系统其他部位的内皮健康和功能障碍产生影响。这项研究检验了这样一个假设,即 PAH 患者的近端肺动脉中的壁切应力降低,并且相信降低的切应力可能导致肺内皮细胞功能障碍,并因此导致 PAH 进展。使用 MRI 和计算流体动力学(CFD)相结合的方法构建了个体特异性肺动脉模型,并量化了 5 名中重度 PAH 患者和 5 名年龄和性别匹配的对照组的血流特征和壁切应力(WSS)。三维模型重建显示,PAH 患者的主肺动脉、右肺动脉和左肺动脉直径明显增大(3.5 ± 0.4 对 2.7 ± 0.1 cm,P = 0.01;2.5 ± 0.4 对 1.9 ± 0.2 cm,P = 0.04;和 2.6 ± 0.4 对 2.0 ± 0.2 cm,P = 0.01),心输出量降低(3.7 ± 1.2 对 5.8 ± 0.6 L/min,P = 0.02)。CFD 显示,与对照组相比,PAH 患者的中心肺动脉平均壁切应力明显降低(4.3 ± 2.8 对 20.5 ± 4.0 dynes/cm(2),P = 0.0004)。远端 WSS 没有显著差异。使用一种新的测量 WSS 的方法首次证明,在一些 PAH 患者中,WSS 发生了改变。使用个体特异性模型中的计算模型,发现 PAH 患者的近端肺动脉中的 WSS 明显低于对照组。近端肺动脉中的低 WSS 可能在 PAH 的发病机制和进展中发挥作用。这些数据可以为未来的体外研究提供依据,例如,WSS 对基因表达的影响。